Bionano Genomics - Dynasty Building 101 BIONA
Post# of 82
(Total Views: 133)
Posted On: 07/13/2025 9:02:15 AM
Bionano Genomics - Dynasty Building 101
BIONANO GENOMICS has orchestrated a powerful alliance across technology, automation, software, and clinical diagnostics to bring Optical Genome Mapping (OGM) to market with precision and scale. MICROSOFT provides the cloud infrastructure that powers high-speed genomic analysis, while BioDISCOVERY’s software suite integrates OGM with other genomic platforms for seamless interpretation. DIAGENS enhances diagnostic accuracy through AI-driven analysis, especially in reproductive health, and LINEAGEN delivers clinical testing directly to patients, validating OGM’s utility in neurodevelopmental disorders. REVVITY supports reagent consistency and workflow automation, ensuring global scalability. HAMILTON and TECAN round out the ecosystem by automating sample preparation and lab workflows, making OGM plug-and-play for clinical labs. Together, these partners form a synchronized pipeline, from DNA extraction to clinical insight, that positions OGM as a disruptive yet enduring force in precision medicine.
Microsoft (MSFT) $503.32 a share
Revvity (RVTY) $101.50 a share
Bionano Genomics (BNGO) $3.40 a share
“If you want to soar like an eagle, don’t hang out with turkeys.”
BIONANO GENOMICS has orchestrated a powerful alliance across technology, automation, software, and clinical diagnostics to bring Optical Genome Mapping (OGM) to market with precision and scale. MICROSOFT provides the cloud infrastructure that powers high-speed genomic analysis, while BioDISCOVERY’s software suite integrates OGM with other genomic platforms for seamless interpretation. DIAGENS enhances diagnostic accuracy through AI-driven analysis, especially in reproductive health, and LINEAGEN delivers clinical testing directly to patients, validating OGM’s utility in neurodevelopmental disorders. REVVITY supports reagent consistency and workflow automation, ensuring global scalability. HAMILTON and TECAN round out the ecosystem by automating sample preparation and lab workflows, making OGM plug-and-play for clinical labs. Together, these partners form a synchronized pipeline, from DNA extraction to clinical insight, that positions OGM as a disruptive yet enduring force in precision medicine.
Microsoft (MSFT) $503.32 a share
Revvity (RVTY) $101.50 a share
Bionano Genomics (BNGO) $3.40 a share
“If you want to soar like an eagle, don’t hang out with turkeys.”
(0)
(0)